Detailed information for compound 153096

Basic information

Technical information
  • TDR Targets ID: 153096
  • Name: 1-[4-(2-fluoroanilino)-8-methylquinolin-3-yl] butan-1-one
  • MW: 322.376 | Formula: C20H19FN2O
  • H donors: 1 H acceptors: 2 LogP: 5.26 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCC(=O)c1cnc2c(c1Nc1ccccc1F)cccc2C
  • InChi: 1S/C20H19FN2O/c1-3-7-18(24)15-12-22-19-13(2)8-6-9-14(19)20(15)23-17-11-5-4-10-16(17)21/h4-6,8-12H,3,7H2,1-2H3,(H,22,23)
  • InChiKey: CYXVKSUVGNDCCO-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 1-[4-(2-fluoroanilino)-8-methyl-3-quinolyl]butan-1-one
  • 1-[4-(2-fluoroanilino)-8-methyl-3-quinolyl]-1-butanone
  • 1-[4-[(2-fluorophenyl)amino]-8-methyl-quinolin-3-yl]butan-1-one
  • 1-[4-[(2-fluorophenyl)amino]-8-methylquinolin-3-yl]butan-1-one
  • 1-[4-[(2-fluorophenyl)amino]-8-methyl-3-quinolyl]butan-1-one

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma cruzi hypothetical protein, conserved 0.0039 0 0.5
Mycobacterium tuberculosis Probable epoxide hydrolase EphA (epoxide hydratase) (arene-oxide hydratase) 0.0159 0.0951 0.2423
Mycobacterium ulcerans putative transglutaminase-like protein 0.0533 0.3925 1
Echinococcus multilocularis Transglutaminase 0.0533 0.3925 1
Leishmania major hypothetical protein, conserved 0.0039 0 0.5
Giardia lamblia Hypothetical protein 0.0533 0.3925 0.5
Loa Loa (eye worm) hypothetical protein 0.009 0.0406 1
Brugia malayi hypothetical protein 0.009 0.0406 0.1035
Toxoplasma gondii ABC1 family protein 0.0039 0 0.5
Giardia lamblia Transglutaminase/protease, putative 0.0533 0.3925 0.5
Mycobacterium tuberculosis Hypothetical protein 0.0533 0.3925 1
Loa Loa (eye worm) hypothetical protein 0.009 0.0406 1
Mycobacterium ulcerans transglutaminase family protein 0.0533 0.3925 1
Plasmodium vivax hypothetical protein, conserved 0.0039 0 0.5
Mycobacterium leprae Conserved hypothetical protein 0.0533 0.3925 1
Trypanosoma brucei hypothetical protein, conserved 0.0039 0 0.5
Mycobacterium ulcerans hypothetical protein 0.0533 0.3925 1
Mycobacterium leprae Conserved hypothetical protein 0.0533 0.3925 1
Trichomonas vaginalis peptide N-glycanase, putative 0.0533 0.3925 1
Brugia malayi Thioredoxin family protein 0.0533 0.3925 1
Trypanosoma cruzi hypothetical protein, conserved 0.0039 0 0.5
Mycobacterium ulcerans hypothetical protein 0.0533 0.3925 1
Schistosoma mansoni eyes absent homolog 0.009 0.0406 0.1035
Mycobacterium tuberculosis Conserved hypothetical protein 0.0533 0.3925 1
Mycobacterium tuberculosis Conserved protein 0.0533 0.3925 1
Echinococcus granulosus Transglutaminase 0.0533 0.3925 1
Schistosoma mansoni hypothetical protein 0.0533 0.3925 1
Mycobacterium ulcerans epoxide hydrolase EphA 0.0159 0.0951 0.2423
Mycobacterium tuberculosis Conserved hypothetical protein 0.0533 0.3925 1
Mycobacterium tuberculosis Possible penicillin-binding protein 0.0249 0.167 0.4256
Mycobacterium tuberculosis Long conserved protein 0.0533 0.3925 1

Activities

Activity type Activity value Assay description Source Reference
Inhibition (functional) = 29 % Inhibition of pentagastrin-stimulated gastric acid secretion at a single dose of 10 micromol/kg. ChEMBL. 7629813
Inhibition (functional) = 29 % Inhibition of pentagastrin-stimulated gastric acid secretion at a single dose of 10 micromol/kg. ChEMBL. 7629813
Inhibition (binding) = 53 % Inhibition of K+ -stimulated gastric ATPase activity was measured using lyophilized gastric vesicles at pH 7 ChEMBL. 7629813
Inhibition (binding) = 53 % Inhibition of K+ -stimulated gastric ATPase activity was measured using lyophilized gastric vesicles at pH 7 ChEMBL. 7629813

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.